Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P. Papp M, et al. Among authors: fechner k. J Hepatol. 2013 Sep;59(3):457-66. doi: 10.1016/j.jhep.2013.04.018. Epub 2013 Apr 29. J Hepatol. 2013. PMID: 23639483
Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Papp M, et al. Among authors: fechner k. J Crohns Colitis. 2015 Aug;9(8):659-68. doi: 10.1093/ecco-jcc/jjv087. Epub 2015 May 12. J Crohns Colitis. 2015. PMID: 25968583 Clinical Trial.
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Tornai T, Tornai D, Sipeki N, Tornai I, Alsulaimani R, Fechner K, Roggenbuck D, Norman GL, Veres G, Par G, Par A, Szalay F, Lakatos PL, Antal-Szalmas P, Papp M. Tornai T, et al. Among authors: fechner k. Sci Rep. 2018 Jan 10;8(1):399. doi: 10.1038/s41598-017-18622-1. Sci Rep. 2018. PMID: 29321484 Free PMC article.
Serological Diagnosis of Autoimmune Bullous Skin Diseases.
Saschenbrecker S, Karl I, Komorowski L, Probst C, Dähnrich C, Fechner K, Stöcker W, Schlumberger W. Saschenbrecker S, et al. Among authors: fechner k. Front Immunol. 2019 Aug 20;10:1974. doi: 10.3389/fimmu.2019.01974. eCollection 2019. Front Immunol. 2019. PMID: 31552014 Free PMC article. Review.
Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.
van Beek N, Rentzsch K, Probst C, Komorowski L, Kasperkiewicz M, Fechner K, Bloecker IM, Zillikens D, Stöcker W, Schmidt E. van Beek N, et al. Among authors: fechner k. Orphanet J Rare Dis. 2012 Aug 9;7:49. doi: 10.1186/1750-1172-7-49. Orphanet J Rare Dis. 2012. PMID: 22876746 Free PMC article.
103 results